Reference: https://www.mobileodt.com/products/eva-pro/ (Accessed 24/08/23)
Female Health Technology (FemTech)
Enhanced Visual Assessment (EVA) System
High Technology for Women’s Health
Digital Colposcopy – a light and portable, complete digital solution for magnified cervical visualization, documentation and teleconsultation.
EVA SOFTWARE – App and Portal
The EVA System simplifies the medical workflow by combining high-quality optics, image and video capture with secure, HIPAA-compliant online data management. It allows for the documentation of cases, annotations and filters added directly to images, and the exportation of information into electronic medical records (EMR).
Redefining Cervical Examination
EVAPro | Digital innovation in cervical cancer screening – enhancing the patient-physician experience.
The EVAPro digital colposcope is light weight and mobile, providing an outstanding image quality with superior software capabilities. This combination allows you to document and track the full treatment process and store it on the cloud.
Features:
- Built with a camera with magnifying capabilities. Superior image quality.
- Optimal work process – Healthy posture; Handwave image capture; Digital touch screen.
- EMR on the EVA Portal – Secure, HIPAA-compliant online data management. Unlimited web storage. Store, manage and export the information simplifying the medical workflow.
- Sophisticated software EVA App – Document cases, add annotations and filters directly to images.
- Green Filter – For improved visualization of vascularity.
Reference: https://www.mobileodt.com/products/eva-pro/ (Accessed 24/08/23)
How does it work?
Capture high quality images
Achieve superior image quality utilizing a proprietary image guided technology.
Document and annotate images with the EVA VisualCheck Software
Save images with notes, annotate biopsy and points of interest, add clinical impression. Unlimited web storage of images, with easy access.
Utilize embedded telehealth capabilities
Securely share patient cases with colleagues or relevant organizations for assessment, utilizing embedded telehealth capabilities.
Educate patients
Empower patients, with collaborative image review. Enhance awareness and understanding of their anatomy.
VisualCheck
The Enhanced Visual Assessment (EVA) System involves a portable colposcope that can be used for digital cervicography. VisualCheck is an image AI classifier to predict the assessment of cervical images by expert colposcopists – images captured with different device models, geographies, and users.
Automated visual evaluation (AVE) is a deep learning computer application for cervical cancer screening.
VisualCheck is an automated visual evaluation of images of the cervix for the qualitative detection of abnormalities that may indicate the presence of dysplasia or neoplasia on the cervix.
VisualCheck estimates what an expert clinician may conclude upon reviewing the images in question, providing information that may be useful in the characterization of suspected positive findings of colposcopy during image interpretation.
VisualCheck software is classified as a medical device with CE-marking.
References: Xue Z, Novetsky AP, Einstein MH, et al. A demonstration of automated visual evaluation of cervical images taken with a smartphone camera. Int. J. Cancer. 2020;147:2416–2423. https://doi.org/10.1002/ijc.33029.
For more information: MobileODT website: https://www.mobileodt.com/ (Accessed 23/05/23)
References: Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial Leeya F Pinder, Groesbeck P Parham, Partha Basu, Richard Muwonge, Eric Lucas, Namakau Nyambe, Catherine Sauvaget, Mulindi H Mwanahamuntu, Rengaswamy Sankaranarayanan, Walter Prendiville. Lancet Oncol 2020 Jan;21(1):175-184.
For more information: https://www.mobileodt.com/products/thermo-glide/ (Accessed 24/08/23)
An immediate point-of-care treatment for precancerous lesions within a single sitting.
ThermoGlide is lightweight, portable, and battery-run.
ThermoGlide does not require complex training. It could be used by non-OB/GYN physicians and providers that are not trained to perform LEEP*, increasing the availability of cervical precancer treatment.
* Loop electrosurgical excision procedure (LEEP) uses a wire loop heated by electric current to remove cells and tissue in a woman’s lower genital tract.
ThermoGlide allows the clinician to treat lesions that appear during a cervical examination, safely and effectively, with minimal side effects. The procedure does not require general anesthetic and most women report mild or moderate discomfort.
How does it work?
The ThermoGlide uses heat to decimate tissue. The probe is heated quickly within 8 seconds and remains at 100°C allowing for rapid cervical ablation. The superficial epithelium withers and dissipates after the treatment, while the stroma and glandular crypts are destroyed. Thermo coagulation offers shorter treatment time as compared to cryotherapy.
HPV Antigen Rapid Test and Delphi Vaginal Self Sampler
- Immediate Results at Point-of-Care.
- No Laboratory Required.
The HPV Antigen Rapid Test Device is a rapid visual immunoassay for the qualitative presumptive detection of HPV 16/18/31/33/45/52/58; and E6 & E7 oncoproteins in female cervical lavage specimens. This kit is intended to be used as an aid in the diagnosis of cervical pre-cancer and cancer.1
Research has demonstrated a correlation of E6 and E7 oncoprotein positivity with both the severity of cervical histopathology and the risk for progression. E6 and E7 oncoproteins are an appropriate biomarker of HPV-mediated oncogenic activity.2
Cervical epithelial cells should be collected by the Delphi Vaginal Self-Sampler.
Reference:
- Data on file.
- Bhattacharjee, R et al. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies. Critical Reviews in Oncology/Hematology, Volume 174, 2022, 103675. ISSN 1040-8428. https://doi.org/10.1016/j.critrevonc.2022.103675.
Point-of-Care single sitting solution for Cervical Health
A full turnkey programme of visual inspection and treatment at point of care within a single sitting. This programme is in line with WHO strategic directive and recommendations to eliminate cervical cancer.
This comprehensive solution, powered by AI capabilities, allows an unprecedented screening scale, combined with immediate treatment option to reduce patient loss to follow-up.
SCREEN AND TREAT!
Reference: https://www.mobileodt.com/products (Accessed 10/08/23)